메뉴 건너뛰기




Volumn 24, Issue 12, 2010, Pages 753-762

Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG DEPENDENCE; EDUCATION; EMPLOYMENT; FEAR; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEPATITIS C; HUMAN; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRELAND; LIVER BIOPSY; MALE; MEDICAL SPECIALIST; PATIENT CARE; PRIMARY MEDICAL CARE; QUALITATIVE RESEARCH;

EID: 78650153376     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0142     Document Type: Article
Times cited : (176)

References (27)
  • 1
    • 34548489173 scopus 로고    scopus 로고
    • Global estimates of prevalence of HCV infection among injecting drug users
    • Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18:352-358.
    • (2007) Int J Drug Policy , vol.18 , pp. 352-358
    • Aceijas, C.1    Rhodes, T.2
  • 3
    • 0034622332 scopus 로고    scopus 로고
    • Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: Results of a cross-sectional survey
    • Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry J. Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: Results of a cross-sectional survey. Br Med J 2000;321:78-82.
    • (2000) Br Med J , vol.321 , pp. 78-82
    • Allwright, S.1    Bradley, F.2    Long, J.3    Barry, J.4    Thornton, L.5    Parry, J.6
  • 4
    • 0031725816 scopus 로고    scopus 로고
    • Bloodborne viral infection in Irish injecting drug users
    • Smyth R, Keenan E, O' Connor J. Bloodborne viral infection in Irish injecting drug users. Addiction 1998;93:1649-1656.
    • (1998) Addiction , vol.93 , pp. 1649-1656
    • Smyth, R.1    Keenan, E.2    Connor J, O.'.3
  • 6
    • 2142768286 scopus 로고    scopus 로고
    • Hepatitis C treatment eligibility in an urban population with and without HIV coinfection
    • Adeyemi OM, Jensen D, Attar B, et al. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care STDs 2004;18:239-245.
    • (2004) AIDS Patient Care STDs , vol.18 , pp. 239-245
    • Adeyemi, O.M.1    Jensen, D.2    Attar, B.3
  • 7
    • 33747428796 scopus 로고    scopus 로고
    • Natural history, treatment and prevention of hepatitis C in injecting drug users: An overview
    • Jager J, Limburg W, Kretzschmar M, Postma M, Wessing L, eds Luxembourg: Office for Official Publications of the European Communities
    • Limburg W. Natural history, treatment and prevention of hepatitis C in injecting drug users: An overview. In: Jager J, Limburg W, Kretzschmar M, Postma M, Wessing L, eds. EMCDDA Monographs: Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options. Luxembourg: Office for Official Publications of the European Communities, 2004:21-38.
    • (2004) EMCDDA Monographs: Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options , pp. 21-38
    • Limburg, W.1
  • 8
    • 20144388125 scopus 로고    scopus 로고
    • Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users
    • Strathdee SA, Latka M, Campbell J, et al. Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis 2005;40(S5):304-312.
    • (2005) Clin Infect Dis , vol.40 , Issue.S5 , pp. 304-312
    • Strathdee, S.A.1    Latka, M.2    Campbell, J.3
  • 9
    • 14644390424 scopus 로고    scopus 로고
    • Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
    • Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis 2005;14(S5):313-320.
    • (2005) Clin Infect Dis , vol.14 , Issue.S5 , pp. 313-320
    • Doab, A.1    Treloar, C.2    Dore, G.J.3
  • 10
    • 34247897359 scopus 로고    scopus 로고
    • Management of hepatitis C among drug users attending general practice in Ireland: Baseline data from the Dublin Area Hepatitis C in General Practice Initiative
    • Cullen W, Stanley J, Langton D, Kelly Y, Bury G. Management of hepatitis C among drug users attending general practice in Ireland: Baseline data from the Dublin Area Hepatitis C in General Practice Initiative. Eur J Gen Pract 2007;13:5-12.
    • (2007) Eur J Gen Pract , vol.13 , pp. 5-12
    • Cullen, W.1    Stanley, J.2    Langton, D.3    Kelly, Y.4    Bury, G.5
  • 12
    • 23744484452 scopus 로고    scopus 로고
    • Barriers to the treatment of hepatitis C: Patient, provider, and system factors
    • Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C: Patient, provider, and system factors. J Gen Intern Med 2005;20:754-758.
    • (2005) J Gen Intern Med , vol.20 , pp. 754-758
    • Morrill, J.A.1    Shrestha, M.2    Grant, R.W.3
  • 13
    • 72849123569 scopus 로고    scopus 로고
    • Hepatitis C Virus is infrequently evaluated and treated in an urban HIV clinic population
    • Scott JD, Wald A, Kitahata M, et al. Hepatitis C Virus is infrequently evaluated and treated in an urban HIV clinic population. AIDS Patient Care STDs 2009;23:925-929.
    • (2009) AIDS Patient Care STDs , vol.23 , pp. 925-929
    • Scott, J.D.1    Wald, A.2    Kitahata, M.3
  • 14
    • 37049001443 scopus 로고    scopus 로고
    • Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
    • Grebely J, Genoway KA, Raffa JD, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008;93: 141-147.
    • (2008) Drug Alcohol Depend , vol.93 , pp. 141-147
    • Grebely, J.1    Genoway, K.A.2    Raffa, J.D.3
  • 15
    • 0035253612 scopus 로고    scopus 로고
    • Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment
    • Stein MD, Maksad G, Clarke J. Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2001;61:211-215.
    • (2001) Drug Alcohol Depend , vol.61 , pp. 211-215
    • Stein, M.D.1    Maksad, G.2    Clarke, J.3
  • 16
    • 38149032629 scopus 로고    scopus 로고
    • A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV
    • Lally MA, Monstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDs 2008;22:53-63.
    • (2008) AIDS Patient Care STDs , vol.22 , pp. 53-63
    • Ma, L.1    Monstream-Quas, S.A.2    Tanaka, S.3    Tedeschi, S.K.4    Morrow, K.M.5
  • 21
    • 52649147608 scopus 로고    scopus 로고
    • Critically appraising qualitative research
    • Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. Br Med J 2008;337:687-689.
    • (2008) Br Med J , vol.337 , pp. 687-689
    • Kuper, A.1    Lingard, L.2    Levinson, W.3
  • 22
    • 51249109876 scopus 로고    scopus 로고
    • The social production of hepatitis C risk among injecting drug users: A qualitative synthesis
    • Rhodes T, Treloar C. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction 2008;103:1593-1603.
    • (2008) Addiction , vol.103 , pp. 1593-1603
    • Rhodes, T.1    Treloar, C.2
  • 23
    • 33846687361 scopus 로고    scopus 로고
    • Chronic illness experiences, clinical markers and living with hepatitis C
    • Sutton R, Treloar C. Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol 2007;12:330-340.
    • (2007) J Health Psychol , vol.12 , pp. 330-340
    • Sutton, R.1    Treloar, C.2
  • 24
    • 0036723341 scopus 로고    scopus 로고
    • Pattern and process in disclosure of health status by women with iatrogenically acquired hepatitis C
    • Dunne E, Quayle E. Pattern and process in disclosure of health status by women with iatrogenically acquired hepatitis C. J Health Psychol 2002;7:565-582.
    • (2002) J Health Psychol , vol.7 , pp. 565-582
    • Dunne, E.1    Quayle, E.2
  • 25
    • 60249099541 scopus 로고    scopus 로고
    • Barriers and facilitators related to mammography use among lower educated Mexican women in the USA
    • Tejeda S, Thompson B, Coronado GD, Martin DP. Barriers and facilitators related to mammography use among lower educated Mexican women in the USA. Soc Sci Med 2009; 68:832-839.
    • (2009) Soc Sci Med , vol.68 , pp. 832-839
    • Tejeda, S.1    Thompson, B.2    Coronado, G.D.3    Martin, D.P.4
  • 26
    • 0034568364 scopus 로고    scopus 로고
    • Audit of blood-borne virus infections in injecting drug users in general practice
    • Peat M, Budd J, Burns SM, Roberston R. Audit of blood-borne virus infections in injecting drug users in general practice. Comm Dis Public Health 2000;3:244-246.
    • (2000) Comm Dis Public Health , vol.3 , pp. 244-246
    • Peat, M.1    Budd, J.2    Burns, S.M.3    Roberston, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.